Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older, of any gender
- People who have been diagnosed with a specific type of lymphoma called Nodal Marginal Zone Lymphoma (NMZL), confirmed by a lymph node tissue sample taken after January 1st, 2000
- People for whom a stored tumour tissue sample from a lymph node is available — either frozen or preserved in a special wax (FFPE) — that was collected before any treatment was given
- People for whom baseline (starting point) and follow-up medical records and information are available
Who may not be able to join:
- People whose lymphoma in the lymph nodes has been found to have spread from a hidden primary lymphoma that started outside the lymph nodes (the trial requires that this possibility has been carefully ruled out using imaging or a camera examination of the relevant areas)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Davide Rossi, MD, Oncology Institute of Southern Switzerland and Institute of Oncology Research
Phone: +41586667321
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Define and quantify molecular subsets.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.